Ocular effects following aqueocentesis in dogs using variable needle sizes: fluorophotometric and tonometric evaluation by Allbaugh, Rachel A.
   
OCULAR EFFECTS FOLLOWING AQUEOCENTESIS IN DOGS USING 
VARIABLE NEEDLE SIZES: FLUOROPHOTOMETRIC AND TONOMETRIC 
EVALUATION 
 
 
by 
 
 
 
RACHEL A. ALLBAUGH 
 
 
 
B.S., Iowa State University, 2000 
D.V.M., Iowa State University, 2004 
 
 
 
A THESIS 
 
 
submitted in partial fulfillment of the requirements for the degree 
 
 
 MASTER OF SCIENCE 
 
 
Department of Clinical Sciences 
College of Veterinary Medicine 
 
 
 
 
KANSAS STATE UNIVERSITY 
Manhattan, Kansas 
 
 
2009 
 
Approved by: 
 
 
Major Professor 
Amy J. Rankin, DVM, MS 
Diplomate ACVO 
 Abstract 
Objective – To measure blood aqueous-barrier breakdown following aqueocentesis using 
various needle sizes and to monitor the intraocular pressure (IOP) response. 
Animals – 24 healthy, adult dogs received treatment (24 treated eyes, 24 contralateral 
eyes); 3 dogs were untreated controls (6 control eyes). 
Procedures – Dogs receiving treatment were divided into 3 equal groups (25-, 27-, or 30-
gauge needle aqueocentesis). In each dog the treated eye was determined randomly, the 
contralateral eye was untreated. Dogs that did not have aqueocentesis performed in either eye 
were used as controls. Aqueocentesis at the lateral limbus was performed under sedation and 
topical anesthesia. Anterior chamber fluorophotometry was performed before and after 
aqueocentesis on day 1. On days 2-5 sedation and fluorophotometry were repeated. Intraocular 
pressure was measured with a rebound tonometer at multiple time points.  
Results – Aqueocentesis resulted in blood-aqueous barrier breakdown in all treated eyes 
with barrier reestablishment present by day 5 detected by fluorophotometry. On day 2 the 
contralateral untreated eyes of all groups also showed statistically significant increased 
fluorescence (P < 0.05) following treatment of the opposite eye, but these values were not 
statistically significantly greater than untreated controls. In treated eyes there was no statistical 
difference in fluorescein concentration or IOP between 27- and 30-gauge needles. Use of the 25-
gauge needle resulted in a statistically significant increase in anterior chamber fluorescence on 
days 3 and 5. It also caused a statistically significant increase in IOP 20 minutes following 
aqueocentesis as compared to the 27- and 30-gauge needles. Aside from this transient ocular 
hypertension, rapid resolution of ocular hypotony following aqueocentesis was observed in all 
treatment groups.  
Conclusions and Clinical Relevance – Aqueocentesis using a 25-gauge needle resulted 
in a greater degree of blood-aqueous barrier breakdown and a brief state of intraocular 
hypertension following paracentesis. Use of a 27- or 30-gauge needle is recommended for 
aqueous paracentesis. A consensual ocular reaction appeared to occur in dogs following 
unilateral traumatic blood-aqueous barrier breakdown and may be of clinical significance. 
Statistical significance was limited in this study due to high variability and large standard 
deviations.  
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CHAPTER 1 - Literature Review 
Aqueous Humor 
Aqueous Humor Dynamics 
Aqueous humor is the optically clear fluid that fills the anterior and posterior chambers in 
the anterior portion of the eye.1 Normal aqueous humor is nearly acellular with very low protein 
concentration.2 Though this transparent liquid occupies spaces in the eye, it is not a static fluid 
body. It is actually a slowly flowing stream which provides nutrition to the intraocular structures 
and allows removal of metabolic waste products.3 Proportionately, the eye contains the largest 
avascular mass found in any organ in the body with blood vessels not normally present in the 
cornea, lens, vitreous or trabecular meshwork.4 Nutrition of these avascular structures is 
accomplished primarily by aqueous humor.4  
Aqueous humor is formed by the ciliary body in the posterior chamber of the eye. Ciliary 
processes are composed of blood vessels embedded in a loose connective tissue stroma with a 
double layer of epithelial cells lining the inner surface.4 Aqueous humor originates from the 
vascular sinuses within these folds and processes, fills the posterior chamber, flows through the 
pupil into the anterior chamber, and drains into the iridocorneal angle.5 The rate of aqueous 
humor formation varies among species and is roughly 2 µl/min in humans4 compared to 4.54 
µl/min in dogs.6 
Aqueous humor is formed by three different mechanisms: diffusion, ultrafiltration, and 
active secretion by the ciliary process epithelial cells. Diffusion of solutes occurs down a 
concentration gradient across the ciliary epithelial barrier while ultrafiltration occurs when 
movement of water or a compound across a cell membrane is increased by a hydrostatic force.7 
The latter results from differences between the ciliary body capillary pressure and intraocular 
pressure;1 however, it has recently been suggested that ultrafiltration has little if any role in 
aqueous humor formation.7 Both diffusion and ultrafiltration are examples of passive processes. 
In contrast, active transport of certain solutes, most notably Na and Cl, by the ciliary body 
epithelium is the principal component of aqueous humor formation and drives fluid inflow from 
the ciliary body stroma to the posterior chamber.4,7-11 Present in the ciliary epithelium, the 
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membrane-bound enzyme complex sodium-potassium-ATPase actively transports sodium ions 
from blood to the aqueous humor.1 Chloride ions enter the posterior chamber through 
electroneutral transporters and chloride channels, and represent the principal anion secreted by 
the ciliary epithelium.8 In addition, the enzyme carbonic anhydrase catalyzes the reversible 
hydration of carbon dioxide by the reaction: CO2 + H2O  HCO3- + H+. Both cytosolic carbonic 
anhydrase isoform II and membrane-bound isoform IV have been identified in the ciliary 
epithelium with net transepithelial bicarbonate transport thought to result from the two 
isoenzymes’ combined effect.7 Entry of sodium, chloride, and to a lesser extent, bicarbonate ions 
into the posterior chamber generates an osmotic gradient and results in transepithelial fluid 
secretion across the ciliary epithelium.7 Modulating ciliary epithelial enzyme function impacts 
aqueous humor production with carbonic anhydrase inhibitors causing up to 50-60% reduction in 
the formation of aqueous.12-15  
Drainage of aqueous humor from the eye is via the iridocorneal angle using the 
conventional route as well as the unconventional uveoscleral outflow pathway.5 The 
conventional route of drainage is via the iridocorneal angle, through the trabecular meshwork 
and into the angular aqueous plexus in most species or Schlemm’s canal in primates.1 
Unconventional outflow is used to varying degrees in different species with fluid leaving by 
diffusion through the iris, ciliary body, and vitreous.1 Studies in dogs using fluorescein-labeled 
dextran and different sized microspheres have shown that in uveoscleral outflow aqueous leaks 
into the interstitial spaces of the uvea to become part of the tissue fluid, with fluid then moving 
through the ciliary muscle into the supraciliary and suprachoroidal spaces to be absorbed by the 
choroidal and scleral circulation.16,17 In normal dogs, uveoscleral outflow accounts for 15% of 
aqueous drainage but in glaucomatous eyes uveoscleral outflow is markedly reduced.18 
In the continuous process of aqueous humor formation and drainage intraocular pressure 
(IOP) is created.5 The rate of aqueous humor formation from within the ciliary stromal tissue is 
influenced by humoral and autonomic innervation so that constant IOP is sustained.1 A normal 
IOP is essential for maintaining the shape of the eye, sustaining its refractive properties, and 
preserving the close association between the retina and choroid.5,8  
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Tonometry 
The balance of aqueous humor formation and drainage helps to maintain a constant 
normal pressure in the eye. Pressure in the normal human aqueous and vitreous averages 15.5 
mm Hg.3 The normal IOP of most animals is usually between 15 and 25 mm Hg due to 
conservation between species.19 Intraocular pressure can be measured experimentally by 
cannulation of the eye, but this is an invasive and complicated technique.3  
Tonometry is the indirect measurement or estimation of IOP through the cornea. 
Historically, tonometers have been used that fall into two categories, those that indent the cornea 
and those that flatten, or applanate, the cornea.3 Indentation tonometers provide reasonable 
estimations of IOP but are not considered as accurate as applanation tonometers.19 Applanation 
tonometers are easier to employ and the portable, reliable TonoPen® instrument is very popular 
among veterinary ophthalmologists. Studies using the Tono-Pen® applanation tonometer, report 
the normal mean canine IOP to be 16.7 +/- 4.0 mm Hg20 and 19.2 +/- 5.9 mm Hg.21 
Disadvantages of this device are that it has difficulty measuring very low IOPs20 and that it has 
been reported to overestimate IOP at lower pressures and underestimate IOP at higher 
pressures.22  
A recently developed intraocular pressure measuring device is the induction-impact, or 
rebound, tonometer. A rebound tonometer has a magnetized probe propelled to come into contact 
with and then rebound from the corneal surface, with the rebound motion characteristics detected 
by a sensing coil and used to calculate IOP.23 The disposable probe has a round plastic tip 1 mm 
in diameter to prevent corneal damage. Due to its small size, topical corneal anesthesia is not 
necessary for IOP measurement as compared to indentation and applanation tonometers used in 
clinical settings. Results of a study by Baudouin and Gastaud documented a significant decrease 
in tonometrically-measured IOP following application of oxybuprocaine and betoxycaine topical 
anesthetics;24 however, in another study no significant difference was present after the 
application of lidocaine topically.23 The rebound tonometer is well-tolerated by dogs, provides 
rapid, reproducible measurements in both normal and glaucomatous animals, and can measure 
intraocular pressure values from 0 to 99 mm Hg.23 In a recent study, IOPs were measured in dogs 
using both the Tono-Pen® applanation tonometer and the TonoVet® rebound tonometer and 
found to be comparable (mean IOP ± SD: Tono-Pen® 12.9 ± 2.7 mm Hg, TonoVet® 10.8 ± 3.1 
mm Hg).25 The two tonometers have also been shown to provide similar measurements following 
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intraocular surgery in dogs.26 In 2006, Gorig et al used freshly enucleated canine eyes to 
compare manometric and tonometric measurements and found that the induction-impact 
tonometer was the most accurate, while with the Tono-Pen® and MacKay-Marg® applanation 
tonometers were increasingly less accurate as the IOP was elevated.23 
Tonometry is an essential diagnostic procedure used during examinations to evaluate 
abnormal eyes and to monitor glaucomatous eyes. With glaucoma, elevated pressure levels 
related to reduced aqueous outflow are present in the eye.4 Ocular hypertension is generally 
associated with the glaucoma disease complex, but can also be present immediately following 
intraocular surgery. Postoperative ocular hypertension is a transient increase in IOP (>25 mm 
Hg) that occurs within 72 hours following cataract surgery and may occur in as many as 50% of 
cases.27 Intraocular pressures remaining greater than normal for a prolonged period of time can 
lead to irreversible damage to the retina and optic nerve and therefore require prompt treatment. 
Pressures lower than the normal range, ocular hypotension, may be present in eyes with uveitis. 
Prolonged hypotension may result in shrinking of the globe, or phthisis bulbi. Monitoring IOP is 
imperative with ocular disease and it is for this reason that tonometry has become a standard 
measure during complete ophthalmic examinations in both humans and animals. 
It has been shown that body position can alter intraocular pressure in dogs as measured 
by tonometry and that the sternal recumbent position may allow for the most consistent and 
repeatable IOP measurements in research investigations.28 Physiologic variables such as changes 
in extraocular muscle tone and eyelid contraction may also alter IOP measurements. These 
factors are possible mechanisms by which systemic anesthetic drugs affect IOP. In one study, 
dogs administered 5 mg/kg ketamine and 10 mg/kg ketamine with 0.5 mg/kg diazepam had 
significantly increased IOP over baseline values.29 An unexplained finding in this study was why 
dogs administered 10 mg/kg ketamine alone did not show a significant IOP change.29 Though 
both patient positioning and anesthetic drug factors are of consequence, it is important to note 
that in both studies IOP differences were only a few mm Hg with no values reported to be above 
the clinically normal canine pressure range.28,29 
Aqueous Humor Centesis 
Anterior chamber paracentesis is used in clinical practice for diagnostic and therapeutic 
purposes to remove aqueous humor fluid from the eye. The procedure can be done on 
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cooperative, awake patients under topical anesthesia, though in some veterinary patients sedation 
or short-acting general anesthesia may be required. Prior to paracentesis the ocular surfaces are 
cleansed with dilute (5%) povidone iodine solution, rinsed with normal saline, and topical 
anesthetic is applied. With the eyelids held open, the bulbar conjunctiva is grasped with small 
forceps near the site of entry and a small needle is inserted bevel up through the perilimbal 
cornea or subconjunctival limbus. The needle enters the eye parallel and anterior to the iris 
avoiding contact with the iris, lens and corneal endothelium. The needle size reported for 
aqueous paracentesis use may range from 25 to 30-gauge.19,30 Once the needle is in the eye, 
aqueous humor fluid is aspirated by a small syringe. An alternative technique is to let the hub of 
the needle fill with fluid without a cumbersome syringe attached, allowing greater control over 
the needle’s position.30 An additional approach more commonly used in humans is to use a 
sterile surgical blade inserted through the peripheral cornea to make a self-sealing stab 
incision.31-33 The technique will vary depending on the indication for paracentesis, the species 
being treated, and the clinician’s preference. 
Aqueous paracentesis is used in clinical practice to collect samples from inside of the 
eyeball for cytological evaluation, culture and sensitivity, antibody determination or other 
diagnostic purposes.2,34-43 Specific ocular diseases where it may be utilized include cases of 
uveitis or intraocular neoplasia. As long as patients are selected appropriately and aseptically 
prepared for the procedure, the technique has been found to be safe with minimal risk of 
complication.38,44 
In addition to diagnostic paracentesis, therapeutic paracentesis is also utilized in a clinical 
setting. Patients with glaucoma or postoperative ocular hypertension may be treated with 
aqueous paracentesis as emergency therapy to rapidly reduce the IOP and prevent damage to the 
retina and optic nerve.19,31-33,45,46 In a human study, cataract surgery patients experiencing 
postoperative ocular hypertension were treated with paracentesis, and though it provided 
immediate reduction in IOP, pressures rebounded to near initial values by one hour after 
treatment.33 Recent human glaucoma studies have combined aqueous paracentesis with medical 
therapy and found that paracentesis provides rapid symptomatic relief, as opposed to medial 
management alone, and can be considered as adjunctive therapy in the management of acute 
elevation of IOP.31,32,45 Therapeutic paracentesis may also be utilized prior to intraocular 
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injection of drugs, such as tissue plasminogen activator, to prevent abnormally elevated pressure 
following drug injection. 
For many decades aqueous paracentesis has been used as a model of intraocular 
inflammation because it causes breakdown of the blood-aqueous barrier with resulting signs of 
uveitis.47-81 Research studies involving paracentesis have allowed detailed study of the blood-
aqueous barrier, have improved our understanding of species-specific differences, and have 
allowed evaluation of therapies to prevent or reduce barrier compromise.  
Anterior chamber centesis is also used in experimental studies to collect aqueous humor 
for analysis of the fluid components. Multiple investigations have measured anterior chamber 
drug levels of various antimicrobial agents following topical, subconjunctival, or systemic 
administration.74,82-88. Aqueous paracentesis is also used to monitor intraocular inflammation by 
analyzing protein, cells, and inflammatory mediators in the fluid. It has been documented that 
aqueous humor in healthy animal species is nearly acellular with low protein concentration and 
only albumin detectable on electrophoresis.2 Increased cellular composition, elevated protein 
values, and other measurable inflammatory mediators in aqueous humor have been used to 
quantify blood-aqueous barrier breakdown in numerous clinical cases and research 
studies.49,50,52,53,57-68,70-73,75,76,78-81,89-95 
Blood-Aqueous Barrier 
Anatomy 
The blood-ocular barriers consist of the blood-aqueous barrier and the blood-retinal 
barrier, functioning to keep the eye as a privileged site by regulating the contents of the ocular 
fluids and protecting the internal ocular tissues from variations which occur constantly in the 
systemic circulation.11 These barriers provide a suitable, highly regulated, chemical environment 
for the avascular, transparent tissues of the eye.11 It is important for optical clarity that virtually 
no protein or cells be present in the ocular fluids as these components would result in light 
scattering and impaired vision.  
The blood-aqueous barrier is composed of tight junctions between the apicolateral 
surfaces of the nonpigmented epithelial cells of the ciliary body processes and between the 
endothelial cells of the iris vasculature.1,11,67 Following intravenous injection of horseradish 
peroxidase, histopathologic examination of normal rabbit eyes demonstrated marker presence in 
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iris vessels and ciliary stroma, but horseradish peroxidase was blocked by zonula occludens of 
the iris endothelial cells and those at the sides of the ciliary process nonpigmented epithelial 
cells.96 It has been shown that the intercellular tight junction proteins occludin and ZO-1 are 
integral components of the blood-aqueous barrier.97,98  
In addition to the nonpigmented ciliary epithelium lateral tight junctions, the morphology 
of the normal bilayered ciliary body epithelium is a formidable barrier to blood-borne substances 
with numerous desmosomes and complicated interdigitations between adjoining nonpigmented 
and pigmented ciliary body epithelial cells.67,99 In the healthy eyes this intercellular pathway 
from the pigment epithelium to the posterior chamber is extremely narrow, long, and tortuous; 
however, in abnormal eyes this pathway becomes much simpler, shorter, and wider due to 
separation of the epithelial cells.99  
A recent review of the blood-aqueous barrier shifts the concept slightly to also include 
the posterior pigmented iris epithelium with tight junctions analogous to those in the 
nonpigmented ciliary epithelium.100 Many years prior, Pedersen observed blockage of 
horseradish peroxidase at the posterior limit of the iris and surmised the presence of zonula 
occludens between the posterior iris epithelium considering they are the only type of junctions 
effective at blocking horseradish peroxidase movement though the intercellular spaces of 
epithelia.101 This finding of similar tight junctions in the posterior iris and nonpigmented ciliary 
epithelium is not surprising as both epithelial tissues originate embryologically from the inner 
layer of the optic cup and are confluent with one another.5 
Given that the non-pigmented ciliary epithelium, posterior iris epithelium, and iris vessels 
are impermeable to albumin,100,102 yet small amounts of protein are present in normal aqueous 
humor,2,92 the source of this protein is believed to be leakage from the ciliary body stroma via the 
iris.100,103 It is well known that ciliary body blood vessels are highly fenestrated and leak most of 
the plasma components into the stroma.1,100,103 Though proteins are prevented from entering the 
posterior chamber by the tight junctions of the ciliary epithelium, proteins can diffuse forward 
along the continuous pathway of loose connective tissue from the ciliary body stroma to that of 
the iris.100 With no epithelium present on the anterior surface of the iris, protein reaching the 
anterior iris surface is able to enter the anterior chamber.100 A kinetic model of fluorescein 
diffusion assessing transfer from plasma, into the iris stroma, and then into the anterior chamber 
closely matched actual findings in rabbit and human eyes.104 This finding supported the 
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conclusion that the principal route of normal aqueous humor plasma-derived protein entry was 
via the iris and not the posterior chamber.100 Thus in normal eyes the posterior chamber is free of 
protein due to the tight junctions of the nonpigmented ciliary and posterior pigmented iris 
epithelium along with the unidirectional flow of aqueous humor forward through the pupil.100 
This modified barrier separates constituents of plasma from the tissues behind the iris and is 
extremely important as there is no functional barrier present between the aqueous humor and the 
vitreous humor.1  
Diurnal protein variations have been detected in the aqueous humor of normal human 
eyes.105 These variations were found to be due to changes in aqueous humor flow rate and not 
changes in blood-aqueous barrier protein permeability as the later was stable over a 24-hour 
period.105 
Blood-Aqueous Barrier Breakdown 
When the anterior segment of the eye becomes traumatized, irritated, or inflamed clinical 
changes that manifest include conjunctival hyperemia, uveal vasodilation, pupillary constriction, 
breakdown of the blood-aqueous barrier, and a transient rise in IOP followed by relative 
hypotony.66,71,72,103 Blood-aqueous barrier breakdown results in leakage of plasma proteins into 
the aqueous humor due to collapse of the epithelial barrier and failure of endothelial cell 
junctions.67 
Disruption of the blood-aqueous barrier can occur following antidromic release of 
endogenous vasodilator substances and from the direct action of prostaglandins.103 Response to 
an irritative stimulus like topical nitrogen mustard depends on intact, sensory innervation and is 
mediated by pain fibers as opposed to prostaglandins or the adrenergic nervous system.66 This is 
supported by the fact that aspirin treatment did not inhibit aqueous humor protein rise after 
topical nitrogen mustard application to rabbit eyes.72 In addition to nitrogen mustard-induced 
irritation, antidromic stimulation of the trigeminal nerve and formaldehyde-induced irritation of 
the eye do not cause prostaglandin release nor are the responses to these stimuli inhibited by 
prostaglandin synthetase inhibitors.106 The mediators of blood-aqueous barrier breakdown 
following trigeminal nerve stimulation are likely sensory neuropeptides like calcitonin gene-
related peptide and substance P.107-110 Substance P-like immunoreactivity was documented in 
rabbit eyes following trigeminal nerve electrical stimulation, and similar ocular signs of miosis 
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and blood-aqueous barrier breakdown were also observed in rabbit eyes after intracameral 
injection of substance P, with the nonsteroidal anti-inflammatory agent indomethacin failing to 
block the effects .107  
Aside from neurogenic stimulation, ocular irritative and inflammatory responses are most 
notably mediated by prostaglandins. Prostaglandins are formed in vivo from metabolism of cell 
membrane arachidonic acid via the cyclooxygenase pathway.111 PGE and PGF2α are the 
predominant metabolites present in ocular tissues during inflammatory events.80 Rabbits 
administered various prostanoids showed a rapid, monophasic response of blood-aqueous barrier 
breakdown to PGE2 and the EP2 selective agonist 11-deoxy PGE1 indicating EP2 receptor 
subtype mediation.112 Paracentesis-induced disruption of the blood-aqueous barrier is mediated 
largely by prostaglandins, most notably E-type, released from the anterior uveal tissues with the 
response minimized by prostaglandin inhibitor treatment.47,49,50,55-57,65,71-73,79,113-115  
As previously discussed, aqueous paracentesis has been used as a model of blood-
aqueous barrier breakdown and has contributed significantly to description of the ocular changes. 
It has been documented that the main site of blood-aqueous barrier disruption is the ciliary 
processes.71,99,106,116,117 Fluorescein angiography has been used to document that after 
paracentesis the ciliary processes are the origin of the protein and fluorescein that enter the 
anterior chamber via the pupil.59 Scanning electron microscopy images of the ciliary body from 
monkey eyes following paracentesis have demonstrated swollen ciliary processes with plasma 
proteins, particularly fibrin, entering the posterior chamber.51 Light and electron microscopy also 
showed prominent structural alterations in the ciliary epithelium of the pars plicata in 
cynomolgus monkey eyes, but these changes were not diffuse with the anterior portion more 
severely affected and the posterior epithelium less disrupted.69 However, following 
prostaglandin-treatment of rabbit eyes, the tracer horseradish peroxidase was seen penetrating the 
anterior and posterior ciliary process nonpigmented epithelium intercellular clefts equally.118  
Even though the ciliary processes are known to be the main site of blood-aqueous barrier 
breakdown, other tissues have also been studied. Following topical application of PGE1 or PGE2 
to rabbit eyes, iris vessels become permeable to horseradish peroxidase with notable leakage into 
the iris stroma.101 On the other hand, posterior inflammation does not appear to result from 
ocular irritation or trauma to the anterior segment. Aqueous paracentesis of rabbit eyes resulted 
in increased aqueous humor PGE2 values; however, PGE2 was not detected in the vitreous, 
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indicating that prostaglandins do not diffuse posteriorly and that they are not released locally 
from posterior segment tissues.119 
Early studies identified the importance of prostaglandins following paracentesis; 
however, given that no drug completely abolished the increase in protein after paracentesis 
injury, it was hypothesized that an antidromic nervous component existed or that the ciliary 
epithelium was mechanically damaged during paracentesis.65,71 Paracentesis-induced blood-
aqueous barrier breakdown has been studied specifically in dogs and results show that 
prostaglandins are indeed the most important mediators of the ocular irritative response, with 
sensory neuropeptides less important and leukotrienes playing no role.47 Though topical 
flurbiprofen significantly reduced blood-aqueous barrier breakdown as measured by anterior 
chamber fluorophotometry,47 the inability to completely abolish the response suggests that 
additional non-prostaglandin, non-sensorineurally-derived mediators may be involved or that the 
rapid reduction in IOP causes physical damage to the blood-aqueous barrier.47,51,54 Similar canine 
studies evaluating other nonsteroidal anti-inflammatory drugs document reduced but not 
abolished aqueous protein increases following paracentesis, again suggesting the blood-aqueous 
barrier breakdown is only partially mediated by prostaglandins.75,76,120 
The sequence of events after paracentesis-induced blood-aqueous barrier breakdown 
involves prostaglandin accumulation followed by anterior chamber protein entry. After 
paracentesis of rabbit eyes, aqueous humor PGE2 and 6-keto-PGF1α values rapidly increased, 
followed by protein increases to maximal levels at 30 minutes.78 The increased protein 
concentration in the reformed, or secondary, aqueous humor has a decreased albumin:globulin 
ratio and increased percent of α- and γ- globulins as opposed to the larger β-globulins.89 An early 
paracentesis study showed that marked hypotony significantly affected the protein content of the 
reformed aqueous, but speed of aspiration and grasping of the conjunctiva with forceps had no 
effect on protein content.121 Neupert and Lawrence also found that final IOP (<12.5 mm Hg) 
after paracentesis may be more important in determining aqueous protein concentration than rate 
of IOP change.89  
Blood-aqueous barrier breakdown is accompanied by a rapid rise in IOP, a response also 
induced by prostaglandins. Various prostaglandins administered topically and systemically have 
been shown to cause transient IOP elevation in animals.122-124 Paracentesis-induced ocular 
hypertension follows blood-aqueous barrier breakdown and is variable between species. Unger et 
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al found rebound hypertension was maximal in treated eyes of rabbits 15-20 minutes following 
paracentesis with pressures 13 mm Hg greater than control values.71 A separate rabbit study 
documented elevated IOP within 15 minutes and lasting 2 hours after paracentesis.67 The ocular 
hypertension is likely due to a sudden rise in the anterior uveal blood volume with a subsequent 
increase in ultrafiltration and plasma extravasion, though blepharospasm and reflex contraction 
of the extraocular muscles may also confound the effect.103,125 In addition to inflow of plasmoid 
aqueous, the role of pupillary block associated with severe miosis was also suggested as rabbit 
eyes pretreated with sector iridectomy had less profound (50% less) pressure elevation after 
paracentesis;67 however, in the study by Unger et al only slight pupillary constriction was 
noted.71 Following paracentesis in cynomolgus monkeys IOP increased rapidly reaching its 
highest value (20 mm Hg) at 3 hours, then returned to normal at 6-9 hours.69  
Though prostaglandins are known to cause increased IOP, other mediators of ocular 
inflammation may also be involved or have similar effects, with variation noted between 
species.126 This is suggested by studies in which nonsteroidal anti-inflammatory agents were 
unable to block the hypertensive response following ocular irritation.72,127  
After blood-aqueous barrier breakdown ocular hypertension persists until aqueous 
outflow increases as compensation, or congestion and edema of the ciliary processes decrease 
aqueous formation.103,109 Prostaglandins are believed to increase aqueous humor drainage via 
uveoscleral outflow, though other mediators may also be associated with the subsequent fall in 
IOP.109,126 Thereafter ocular hypotony ensues, with decreased IOP a common clinical finding in 
uveitis.128  
It is uncertain exactly how long the blood-aqueous barrier takes to recover its function 
after damage with variability likely dependent on type and severity of trauma as well as the 
species affected. After paracentesis of rabbit eyes, increased aqueous humor prostaglandin and 
protein levels decreased to near baseline values 48 hours after trauma indicating almost complete 
resolution.78 In a monkey study involving paracentesis and intravenous horseradish peroxidase, 
breakdown of the blood-aqueous barrier was not functionally repaired even seven days after the 
operation with marker molecules noted in the intercellular spaces beyond the nonpigmented 
ciliary epithelium tight junctions.77 A separate study using cynomolgus monkeys noted persistent 
morphologic differences present in the anterior portion of the pars plicata seven days following 
paracentesis.69  
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In addition to the numerous studies involving paracentesis, other research models have 
also been used to study blood-aqueous barrier breakdown and therapeutic modalities. 
Investigations have utilized topical irritants,48 topical pilocarpine,81,129-131 ocular surgery,132 
anterior segment ischemia,133 laser treatment of the iris59,134 or lens,90,91,127,135 intraocular 
injection of endotoxin,80,93,115,136-138, intravitreal injection of vascular endothelial growth 
factor,139 intravitreal injection of endothelin-1,96 intravitreal injection of adjuvant,115 and a more 
recent ocular perfusion model that does not have to be performed on live animals.140  
Blood-aqueous barrier breakdown associated with anterior uveitis results in the clinical 
changes previously discussed, and if severe may be accompanied by signs of ocular pain, 
epiphora, photophobia, corneal changes, hypopyon, hyphema, and iris changes.141,142 
Consequences of severe or prolonged blood-aqueous barrier breakdown include iris adhesions 
(synechiae), pre-iridofibrovascular membranes, loss of corneal transparency, cataract, lens 
subluxation, glaucoma, and phthisis bulbi.142 Treatment of ocular inflammation utilizing both 
corticosteroids and nonsteroidal anti-inflammatory agents to block production of prostaglandins 
and other metabolites of arachidonic acid is imperative so that vision-threatening sequelae of 
ocular inflammation can be avoided.111,143,144  
Consensual Reactions 
Not only does ocular trauma affect the treated eye, but a consensual reaction has also 
been documented in the contralateral untreated eye of rabbits117,119,145-147 and humans.148 
Following anterior chamber paracentesis of rabbit eyes a rapid rise in PGE2 levels was 
documented in treated eyes as well as contralateral untreated eyes.119 Scanning electron 
microscopy of rabbit eyes treated with paracentesis and contralateral control eyes demonstrated 
changes in ciliary body processes consistent with both a direct and consensual reaction.117 The 
researchers hypothesized the consensual response was carried from the traumatized to non-
traumatized eye by a neural reflex arc but could not rule out a modulating or mediating role for 
prostaglandins.117 Early studies involving intracameral injections of prostaglandins in rabbit eyes 
resulted in elevated IOP in both the treated and contralateral untreated eye.145,146 The authors 
concluded the consensual reaction was due to a transfer of prostaglandin from the injected eye to 
the opposite eye via systemic blood circulation.145,146 However, a later study involving rabbit 
paracentesis and anterior segment fluorescein angiography found that the consensual responses 
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were more effectively inhibited by nerve-blocking agents than prostaglandin inhibitors and 
therefore the interocular pathway mediating the response was probably neural.147 This is 
supported by the fact that prostaglandins released into the general circulation are rapidly 
inactivated by the liver and lungs so that only scant amounts may reach arterial circulation.147 
The consensual ocular reaction is an important biological finding and is clinically noteworthy as 
it was documented immediately following and then up to one month following cataract surgery 
in humans.148 A study using paracentesis and fluorophotometry in cynomolgus monkeys did not 
find increased fluorescein concentration in the contralateral eye though.70 
Species Variations 
Blood-aqueous barrier breakdown has been studied extensively over the years but there is 
considerable species variation in the responsiveness of the eye to acute insults.125 This variability 
is important to note, especially in regard to research models and when evaluating therapeutic 
strategies. Rabbit eyes are much more responsive to injury than primates and the physiologic 
response is somewhat altered.103 For example, paracentesis in monkeys causes only a mild and 
short-lived breakdown of the blood-aqueous barrier,70 and protein accumulation in the anterior 
chamber following paracentesis in monkeys does not originate from the posterior chamber, 
instead entering the aqueous humor by reflux through Schlemm’s canal.51,69,149 This variability is 
not surprising as a mechanism facilitating blood-aqueous barrier breakdown is advantageous to 
some species but disadvantageous to others. 
A paper by Bito extensively discusses evolutionary divergence in ocular defense 
mechanisms.150 On a physiologic basis, the most pronounced effect of acute blood-aqueous 
barrier breakdown is protein entry into the aqueous humor. This is a primary ocular defense 
mechanism necessary for the rapid delivery of clotting factors into the anterior chamber so that 
penetrating corneal wounds can be rapidly sealed and repaired. It has been shown that those 
animals with more labile blood-aqueous barriers are the most vulnerable to corneal perforation 
because of their morphological, behavioral, and environmental adaptations. These species, such 
as rabbits, rely on monitoring visual systems with laterally placed, somewhat protruding, and 
hence relatively unprotected globes. In contrast, primates have searching type visual systems that 
require visual acuity and stereopsis. These species have well-protected globes and more stable 
blood-aqueous barriers given the obvious disadvantage aqueous humor protein has on visual 
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acuity. There is a positive correlation among species between dependence on visual acuity and 
blood-aqueous barrier stability and a negative correlation between corneal vulnerability and 
blood-aqueous barrier stability.150  
For this reason, extrapolation from rabbits or other species commonly used in ocular 
research is not always appropriate. Comparative studies are valuable, but ultimately 
documentation of a response in species of interest is most important and necessary for evidence 
based medicine. 
Quantification of Blood-Aqueous Barrier Breakdown 
Slit-Lamp Assessment 
Aqueous flare is the result of proteins leaking from systemic circulation into the 
relatively protein-free aqueous humor when the anterior uveal blood vessel integrity and 
epithelial cell junctions are compromised.94 Though the normal aqueous humor is acellular, cells 
can also be observed in the anterior chamber during intraocular inflammation. Cells in the 
aqueous humor originate locally from the uveal tissues or enter the aqueous humor after passing 
through compromised capillary walls and epithelial barriers.141 
Subjective grading of changes in aqueous humor composition with blood-aqueous barrier 
breakdown by slit-lamp examination has been widely employed to quantify aqueous flare 
intensity and cell number in uveitis.141 Normal aqueous humor is optically clear; however, if 
blood-aqueous barrier breakdown occurs protein and cells leak into the aqueous and can be 
visualized in a slit-lamp beam of light passing through the anterior chamber (Tyndall light 
phenomenon).141 Evaluation is performed in a very dark room with intensity of the beam passing 
through the protein-rich aqueous humor subjectively quantified (Figure 1-1).141 Grades for 
aqueous flare include 0 for complete absence, 1+ for faint flare (barely detectable), 2+ for 
moderate flare (iris and lens details clear), 3+ for marked flare (iris and lens details hazy), and 4+ 
for intense flare (fixed, coagulated aqueous humor with considerable fibrin). Aqueous humor cell 
levels are quantified on a similar scale based on cellular density in the beam of light (wide beam 
with narrow slit) with a grading of 0 for no cells, 1+ for 5-10 cells per field, 2+ for 10-20 cells 
per field, 3+ for 20-50 cells per field, and 4+ for 50+ cells per field. Though this method is 
simple, convenient, repeatable and clinically useful, it is subjective, not sensitive, and not 
standardized. Slit-lamp assessment is most applicable in a clinical setting. In research studies, 
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this type of subjective examination has low sensitivity, poor reproducibility, a lack of 
standardization values between different instruments, and suffers from observer bias.151 
 
Figure 1-1 Tyndall light phenomenon demonstrating aqueous flare. 
 
Image courtesy of Dr. Paul Miller 
Fluorophotometry 
Increased concentration of fluorescein in the eye following systemic administration has 
been shown to correlate well with increased protein concentration in the eye, suggesting protein 
and fluorescein pass into the aqueous at the same place (ciliary body) and from the same source 
(blood plasma).73 This basis allows fluorophotometry to be used to quantitatively assess anterior 
chamber inflammation and is an objective means of assessing blood-aqueous barrier breakdown.  
Fluorophotometric evaluation of the blood-aqueous barrier measures the diffusion of 
small fluorescein molecules (MW 376) into the anterior chamber and allows detection of even 
subclinical alterations.152 The amount of fluorescein that enters the anterior chamber following 
systemic administration is proportional to the degree of blood-aqueous barrier disruption, 
allowing anterior chamber fluorophotometry to provide a reliable and noninvasive method of 
evaluating the integrity of the blood-aqueous barrier.54 Following administration of intravenous 
fluorescein, a patient is placed in front of the fluorophotometer and a blue excitation beam scans 
the eye along the optical axis (Figure 1-2). The machine’s optic head receives green fluorescence 
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readings, which are processed by the photodetector and associated computer. Results are 
reported in fluorescein ng/ml and displayed graphically (Figure 1-3). Each scan takes only a few 
seconds, but some animal patients may need sedation or anesthesia to allow proper positioning. 
The cited disadvantages of fluorophotometry are that it requires administration of systemic 
fluorescein with potential adverse reactions153,154 and a short time delay (30-90 minutes) 
necessary before readings can be performed. 
 
Figure 1-2 Ocular fluorophotometry being performed on a canine patient. 
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Figure 1-3 Data generated by the fluorophotometer showing a graphical display of ocular 
fluorescence and equivalent fluorescein concentrations (ng/ml) with peak plateau levels 
present in the anterior chamber.  
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Data reporting and analysis of fluorophotometry results has been performed in a variety 
of ways over the years with methods that include actual fluorescein concentrations, percent 
increase in the treated versus the contralateral eye, percent increase as compared to baseline, and 
calculation of a diffusion coefficient. No one method has shown to be superior. Studies that 
utilize mean anterior chamber fluorescence report results in ng/ml.70,90,135,136,155-159 Investigations 
that report results in percent increase in the treated versus the contralateral eye use the formula: 
%INC FL = {(FLtx – FLuntx)/(FLuntx)} x 100.47,54-56,132,160,161 This method has been used for 
calculation because both eyes equilibrate against the same serum concentration; however, it has 
been stated that this ratio may be deceptive due to a consensual reaction in the contralateral 
unoperated eye.148,152,157 A 2008 study reported results as a percentage increase in the post-
treatment fluorescein concentration over the baseline concentration using the following formula: 
%INC FL = {(FLpost – FLbaseline)/(FLbaseline)} x 100.162 A diffusion coefficient for fluorescein can 
also be calculated by fluorophotometry, providing a physical value for the leakage of fluorescein 
molecules through the blood-aqueous barrier. This method is reliable and reproducible as long as 
a strict protocol is followed, which involves multiple blood samples and numerous 
fluorophotometric measurements per eye.163 This method is less commonly used for 
investigations due to the conclusion that measurement of plasma fluorescence and calculation of 
a diffusion coefficient does not improve the clinical accuracy of anterior chamber 
fluorophotometry.156 Shah et al suggest that the concentration of anterior chamber fluorescence 
(ng/ml) is appropriate for quantification provided that patients are systemically well and are 
given the same dose of fluorescein by the same route.156  Further studies are warranted to 
determine which method of analysis is most appropriate in dogs. 
Anterior chamber fluorophotometry can be used to assess the integrity of the blood-
aqueous barrier in research studies, after intraocular surgery, and during clinical disease 
(uveitis).47,54-56,70,90,93,132,135,139,152,155,157,159-162,164 This method of assessing the functional status of 
the blood-aqueous barrier is simple, sensitive, objective, reproducible, and provides observer-
independent results.155,157,164 Fluorophotometry is able to detect differences that cannot be 
clinically assessed155,160 and provides a longer-lasting indicator of permeability barrier disruption 
than macromolecule leakage.132  
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Laser Flaremetry 
Aqueous humor protein and cells can be noninvasively and objectively quantified by a 
laser flare cell meter.165 The system consists of a helium-neon laser slit lamp, a binocular 
microscope fitted with a photomultiplier, and a personal computer that controls the system and 
analyzes the data (Figures 1-4 and 1-5). The 25 µW helium-neon laser beam has a focused 
diameter of 20 µm and is projected into the anterior chamber with beam scattering detected in a 
sampling window (0.3 x 0.5 mm) by the photomultiplier. Scans lasting only 0.5 seconds are 
performed sequentially for protein concentration and cell count with the total scan time taking 
one second. The laser beam light scattering intensity in the anterior chamber is analyzed and 
results are reported as photon counts of scattered light per millisecond (pc/ms). The test is 
rapidly repeatable and therefore allows demonstration of dynamic changes. 
 
Figure 1-4 Laser flare cell meter. 
 
Image courtesy of Dr. Amy Rankin 
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Figure 1-5 Feline patient positioned in front of the laser flare cell meter. 
 
Image courtesy of Dr. Amy Rankin 
 
Albumin is the major protein constituent of normal aqueous humor and laser flaremetry 
has been shown to reliably predict albumin protein concentration in noninflamed eyes.166 
However, as eyes become progressively more inflamed there is an increase in both the 
concentration and proportion of higher molecular weight molecules, both of which increase light 
scattering and preclude use of a calibration curve based on albumin alone.167 To avoid protein 
overestimation, it is recommended that laser flare results be expressed in either pc/ms or 
converted into an equivalent protein concentration using a calibration curve based on actual 
anterior chamber protein measurements.166,167 Investigation of canine patients confirms that laser 
flaremetry results should be expressed as pc/ms or converted to protein concentration by using 
the dog in vivo calibration curve for comparisons with data of other studies to avoid 
overestimation from use of the albumin curve.92 Others recognize that macromolecules, like 
globulin and lipids, generate stronger scattering effects than albumin, but feel that except in cases 
of very strong inflammation the intensity measured with the laser flare cell meter parallels the 
actual aqueous protein concentration.151 
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Aqueous humor cell count can also be quantified with the laser flare cell meter. A study 
by Krohne et al determined that the cell measuring function was accurate and useful, but did cite 
certain limitations.168 The authors identified a difference between cell sizes and counting 
accuracy and also noted that the instrument counted flare if beads or cells were present, even 
when protein was not present.168 The artifactual flare was attributed to scatter from the cells or 
beads studied, and would not likely cause a problem in clinical or research cases with uveitis due 
to higher expected protein concentrations in diseased eyes.168 One study in humans also 
recognized a limitation in cell counting with the laser flare cell meter as 16.8% of clinical uveitis 
cases graded to have 1+ cells by slit-lamp examination were not detected by the laser flare cell 
meter.151 This was attributed to the limited sampling window and short sampling time of the laser 
flare cell meter as compared to the larger observation volume and arbitrary time of slit-lamp 
examination.151  
Aside from these minor limitations, the laser flare cell meter has been deemed a useful 
clinical and investigative tool for noninvasive, repeatable, quantitative assessment of the blood-
aqueous barrier and has been used in numerous studies.81,92,96,129-131,133,151,152,164,168-170 Laser flare 
and cell measurement is relatively easy to perform and reproducibility is within a reliable range 
for biological systems.164  
Aqueous Humor Microprotein Assays 
Given that aqueous humor protein concentration increases are directly proportional to the 
severity of blood-aqueous barrier breakdown actual protein values can be evaluated.171 In order 
to determine aqueous humor protein a sample of aqueous fluid is collected by paracentesis and 
protein concentration is quantified in mg/dl typically using the Coomassie blue technique for 
microprotein analysis.172 In one study healthy dogs averaged 15.1 mg/dl aqueous protein with a 
range of 5-28 mg/dl,92 while another canine study reported slightly higher normal values 
averaging 36.4 mg/dl and ranging from 21 to 65 mg/dl.2 Though calculation of aqueous humor 
protein has been utilized in numerous studies as an objective measure of blood-aqueous barrier 
breakdown,49,50,57-59,66,68,72,73,75,76,79,81,92,95,138 collection of the sample is invasive and further 
blood-aqueous barrier breakdown complicates sequential measurements. 
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Comparison of Techniques 
In a clinical setting, slit-lamp assessment is the most practical method for evaluating 
blood-aqueous barrier breakdown. The semi-quantitative method of grading aqueous humor flare 
and cells can be performed repeatedly and by different observers, but is therefore subjective and 
insensitive. On the other end of the spectrum, microprotein assays are very sensitive and specific, 
but due to the nature of aqueous collection are invasive and preclude repeated monitoring over 
short periods of time. For these reasons, the fluorophotometer and laser flare cell meter have 
become the primary means of assessing blood-aqueous barrier breakdown in research studies. 
There is widespread debate as to which method is superior, and it has been stated that the two 
techniques may measure different and not identical parameters of blood-aqueous barrier 
function.156  
It is known that the laser flare cell meter measures the barrier function to protein and 
cells, while the fluorophotometer measures the influx of small fluorescein molecules. A 1983 
study in rabbits documented selective barrier reestablishment for different-sized molecules and 
found fluorescein leakage to be a more sensitive and longer-lasting indicator of loss of integrity 
of permeability barriers between the blood and aqueous than macromolecule leakage.132 In a 
1992 human study, fluorophotometry was found to be more sensitive for early blood-aqueous 
barrier changes as compared to laser flaremetry.164 It was stated that in cases of moderate blood-
aqueous barrier dysfunction increased permeation of fluorescein possibly precedes that of bigger 
molecules, whereas albumin passes into the eye in higher quantities with more distinct failure of 
the blood-aqueous barrier.164 Another human study measuring blood-aqueous barrier function 
following cataract surgery found fluorophotometry to be more sensitive than flaremetry in 
detecting small alterations in barrier permeability.152 The need to administer systemic 
fluorescein, wait for steady-state aqueous humor levels, and allow adequate wash-out of 
fluorescein between repeated fluorophotometry measurements has been cited as the main benefit 
to using laser flaremetry.92 Despite these minor differences, both fluorophotometry and laser 
flaremetry are able to provide sensitive, reliable measures of ocular inflammation and both are of 
use in the quantitative assessment of damage to the blood-aqueous barrier.152,156 
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CHAPTER 2 - Ocular Effects Following Aqueocentesis in Dogs 
Using Variable Needle Sizes: Fluorophotometric and Tonometric 
Evaluation 
Introduction 
Ocular anterior chamber paracentesis, or aqueocentesis, is a commonly performed 
procedure for both diagnostic and therapeutic purposes in veterinary medicine. In a clinical 
setting it may be performed in the face of anterior chamber disease to collect a sample of 
material for diagnostic purposes. It is also employed as therapy in emergency management of 
glaucoma to protect the retina from the deleterious effects of elevated intraocular pressure (IOP) 
when refractive to medical means of pressure control. Aqueocentesis is accomplished by 
inserting a 25- to 30-gauge hypodermic needle through the limbal cornea into the anterior 
chamber, with the needle passing parallel to the iris.19 This is commonly performed in a clinical 
setting on awake patients under topical anesthesia alone, though general anesthesia may be 
employed in select cases. It is important to note that aqueocentesis has been shown to cause 
intraocular inflammation by inducing breakdown of the blood-aqueous barrier. For this reason 
anterior chamber paracentesis has been used as a model of intraocular inflammation for research 
investigations in a variety of species.47-76,81 
The ocular blood-aqueous barrier is formed by the endothelium of the iris blood vessels, 
the non-pigmented layer of the ciliary epithelium, and the posterior pigmented epithelium of the 
iris.100 These structures normally prevent substances present in the blood from entering the eye. 
When the barrier is disrupted the blood vessels dilate and plasma proteins leak into the aqueous 
humor.103 Common causes of blood-aqueous barrier breakdown are anterior uveitis, ocular 
surgery, trauma, aqueous paracentesis and ocular irritants. Blood-aqueous barrier breakdown can 
be assessed by subjective ophthalmic examination using a time-honored semiquantitative grading 
scheme, with aqueous flare indicating protein-rich aqueous humor.141 Objective techniques that 
allow for more accurate comparison of blood-aqueous barrier compromise include 
fluorophotometry, laser flaremetry, and aqueous humor protein assays. Anterior chamber 
fluorophotometry noninvasively measures the fluorescein concentration in the anterior chamber 
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following systemic administration of fluorescein. Greater levels of fluorescein entering the 
anterior chamber indicate greater permeability of the blood-aqueous barrier; therefore 
fluorophotometry can be used to quantify the degree of blood-aqueous barrier disruption.  
Considering aqueocentesis is a common diagnostic and therapeutic practice with known 
adverse effects, the question remains whether those adverse effects can be minimized with use of 
a smaller gauge needle. This variable has not been previously studied so no scientifically-based 
recommendations for aqueocentesis needle size are currently reported in the literature. The 
purposes of this study were to use anterior chamber fluorophotometry to evaluate the degree of 
blood-aqueous barrier breakdown following aqueocentesis using variable needle sizes and 
tonometry to track the IOP response.  
Materials and Methods 
Animals 
The use of dogs and all procedures in this study were approved by the Institutional 
Animal Care and Use Committee at Kansas State University. Beagle dogs were obtained 
following use in prior studies unrelated to ophthalmic research, and after completion of our study 
were returned for eventual adoption. Dogs were housed individually in a temperature-controlled 
environment illuminated by fluorescent lights that were automatically turned on (from 8 a.m. to 8 
p.m.) and off. Prior to their inclusion in the study, individual physical and ophthalmologic 
examinations were performed and all dogs were deemed healthy with no confounding 
conditions. Ocular examination included rebound tonometry,a slit-lamp biomicroscopy,b and 
indirect ophthalmoscopy.c Animals were adapted to human contact for a minimum of 3-6 weeks 
during their previous research investigations. Three dogs (two intact males and one intact 
female) were used for preliminary work to determine ideal time points for study design. Twenty-
eight dogs (13 intact male dogs, two neutered male dogs, and 13 intact female dogs) were used 
for the research study with 24 dogs in the treatment groups and 4 dogs in the control group; 
however, one control dog developed a corneal ulcer in one eye and was removed from the study. 
Aqueocentesis 
Twenty-four healthy, adult beagles were divided into 3 equal treatment groups (25-, 27-, 
or 30-gauge needle) by permuted block randomization. In each dog the treated eye was 
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determined randomly by the flip of a coin and the contralateral eye remained untreated. Three 
healthy, adult beagles did not receive treatment in either eye but participated in all other aspects 
of the study and were used as controls with each eye treated as an independent variable.   
Aqueous paracentesis, anterior chamber fluorophotometry, and tonometric measurements 
were all performed by a single investigator (RAA). Animals were sedated with ketamined (8.8 
mg/kg of body weight, IM) and xylazinee (0.88 mg/kg of body weight, IM) prior to 
aqueocentesis and fluorophotometer scans for optimal patient positioning and accurate 
measurements. Topical anestheticf (0.5% proparacaine) and 5% povidone iodine were applied to 
the eye prior to aqueocentesis. Bishop-Harmon forceps grasped the bulbar conjunctiva to 
stabilize the eye and a needle was inserted through the lateral perilimbal cornea parallel to the 
iris (Figure 2-1). Care was taken to avoid the iris, lens, and corneal endothelium. The needle hub 
was allowed to fill half-way and then was rapidly removed from the eye. No effort was made to 
prevent regurgitation of aqueous humor through the corneal puncture site. The aim of our study 
was to evaluate the clinical practice of therapeutic aqueocentesis, therefore uncontrolled 
paracentesis was performed. 
 
Figure 2-1 Globe stabilization and needle positioning for performing aqueocentesis. 
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Fluorophotometry 
A computerized scanning ocular fluorophotometerg with an anterior chamber adapter was 
used to measure fluorescein concentrations in the central anterior chamber of each eye following 
administration of 10% fluoresceinh (20 mg/kg of body weight, IV). Each dog was placed in 
sternal recumbency, the head was stabilized, the eyelids were held open, and the eye was 
positioned in front of the scanner (Figure 2-2). For consistency the left eye was always scanned 
first, followed immediately by the right eye with no more than 2 minutes elapsing between 
measurements at each time point. Aqueous humor fluorescein values are reportedly maximal and 
stable in dogs between approximately 30 and 90 minutes after intravenous injection of 
fluorescein.54 Results from our preliminary work with three dogs confirmed this finding and for 
the research study all fluorophotometry readings were scheduled during this appropriate post-
injection period. Fluorophotometry was performed on sedated dogs prior to and following 
aqueocentesis on day 1, then daily through day 5 (and at equal time points in control dogs). To 
minimize motion during fluorophotometric readings chemical restraint is commonly needed in 
dogs. It has been previously shown that the administration of ketamine and xylazine does not 
alter blood-aqueous barrier permeability.54 
 
Figure 2-2 Patient positioning for ocular fluorophotometry with use of the anterior 
chamber adapter. 
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Tonometry 
All IOP measurements were performed using a rebound tonometer as previously 
described.23,25,173 The measurements were taken with each dog manually restrained sternally, the 
head maintained in an upright position and the eyelids gently held open while avoiding pressure 
on the globe (Figure 2-3). Three consecutive IOP readings were obtained on each eye according 
to manufacturer specifications and IOP was determined as the mean of these readings. Given that 
the cornea would be anesthetized for IOP readings immediately following aqueocentesis, initial 
tonometric readings were taken both prior to and after application of topical anesthetic to 
evaluate for significant variation. One drop of topical anesthetic (0.5% proparacaine) was applied 
to the cornea and tonometry was repeated in the same manner described above. In order to 
maintain consistent and comparable IOP values throughout the study topical anesthesia was 
utilized for every tonometric measurement. 
 
Figure 2-3 Use of the Tono-Vet® rebound tonometer for intraocular pressure 
measurement. 
 
Study Time Points 
The experimental schedule was based on reports from previous studies 54 and results of 
preliminary testing on three dogs. Time points for the 24 treated dogs were as follows 
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(hours:minutes): Day 1 – initial examination and IOP; time 0 IV fluorescein; 0:25 IM sedation; 
0:30 pre-aqueocentesis fluorophotometer scan (baseline); 0:33 pre-aqueocentesis IOP; 0:35 
aqueocentesis; 0:36 1 minute post-aqueocentesis IOP; 0:55 20 minutes post-aqueocentesis IOP; 
1:05 post-aqueocentesis fluorophotometer scan; 1:15 40 minutes post-aqueocentesis IOP; 1:35 
60 minutes post-aqueocentesis IOP; IOP measurements continued every 60 minutes until 8 hours 
following aqueocentesis (Table 2-1). Follow-up ocular examinations were performed 6 hours 
after aqueocentesis. Days 2-5 – examination and IOP; IV fluorescein 1 hour prior to 
fluorophotometry; IM sedation 10 minutes prior to fluorophotometry; fluorophotometer scans 
every 24 hours post aqueocentesis (Table 2-2). Control dogs were studied similarly; however, 
aqueocentesis was not performed and only topical betadine and ophthalmic anesthetic were 
applied to the eyes at 0:35 on Day 1. 
 
Table 2-1 Experimental schedule time points on Day 1 of the study (hours:minutes) 
Time Point Measurement 
Baseline data Initial exam and IOP 
0:00 Intravenous fluorescein 
0:25 Intramuscular sedation 
0:30 Pre-aqueocentesis fluorophotometer scan 
0:33 Pre-aqueocentesis IOP 
0:35 Aqueocentesis 
0:36 1 minute post-aqueocentesis IOP 
0:55 20 minutes post-aqueocentesis IOP 
1:05 Post-aqueocentesis fluorophotometer scan 
1:15 40 minutes post-aqueocentesis IOP 
1:35 60 minutes post-aqueocentesis IOP 
+1:00 Hourly post-aqueocentesis IOPs 
6:35 6 hours post-aqueocentesis ocular examination 
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Table 2-2 Experimental schedule time points on Day 2 of the study (hours:minutes) with 
subsequent daily evaluations every 24 hours through Day 5. 
Time Point Measurement 
23:00 Ocular exam and IOP 
23:35 Intravenous fluorescein 
24:25 Intramuscular sedation 
24:35 Fluorophotometer scan 
End of day Ocular examination 
 
Data Analysis 
Results from this study are reported as mean anterior chamber fluorescence in ng/ml as 
has been used in previous investigations.70,90,135,136,155-159 Additional methods of analyzing 
fluorophotometer results include percent increase in the treated versus the contralateral eye using 
the formula: %INC FL = {(FLtx – FLuntx)/(FLuntx)} x 10047,54-56,132,160,161 and percentage increase 
in the post-treatment fluorescein concentration over the baseline concentration using the formula: 
%INC FL = {(FLpost – FLbaseline)/(FLbaseline)} x 100.162 Though mean fluorescence in ng/ml was 
used as the primary method of analysis in our study, the additional percentage increase methods 
were also employed when comparing between treatment groups. 
A commercial software programi was used for all statistical analyses. Values of P < 0.05 
were considered significant. Intraocular pressure values obtained prior to or following 
application of topical anesthetic were compared using a paired T-test. Anterior chamber 
fluorescein values in the treated versus the contralateral untreated eyes were compared within 
each treatment group using a paired T-test. Treatment groups were compared by repeated 
measures analysis of variance followed by a Newman-Keuls posthoc multiple comparisons test 
to discern individual differences. This method was utilized for both gross anterior chamber 
fluorescein values and percent increase in fluorescence evaluation. Anterior chamber fluorescein 
values in treated or contralateral untreated eyes were compared over time by repeated measures 
analysis of variance followed by a Newman-Keuls posthoc multiple comparisons test to discern 
individual differences. Multiple linear regression was used to evaluate the effect of treatment 
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group on IOP over time and analysis of variance was performed to determine whether there were 
significant differences in IOP measurements at specific time points between treatment groups.  
Results 
Fluorophotometry 
Aqueocentesis caused blood-aqueous barrier disruption using all needle sizes. Evaluating 
all treated eyes as a group, significant increased anterior chamber fluorescence was present at the 
post-aqueocentesis (P < 0.001), day 2 (P < 0.001), day 3 (P = 0.0014) and day 4 (P = 0.0011) 
time points as compared to contralateral untreated eyes (Table 2-3). In the 25-gauge needle 
group a significant difference was present between the treated and contralateral untreated eyes at 
the post-aqueocentesis (P = 0.0163), day 2 (P = 0.0387), and day 3 (P = 0.0428) time points with 
significantly greater anterior chamber fluorescence in the treated eyes (Figure 2-4). In the 27-
gauge needle group a significant difference was present between the treated and contralateral 
untreated eyes at the post-aqueocentesis (P = 0.0017), day 2 (P = 0.001), day 3 (P = 0.001) and 
day 4 (P = 0.002) time points with significantly greater anterior chamber fluorescence in the 
treated eyes (Figure 2-5). In the 30-gauge needle group a significant difference was present 
between the treated and contralateral untreated eyes at the post-aqueocentesis (P = 0.0333), day 2 
(P = 0.0173), and day 3 (P = 0.0078) time points with significantly greater anterior chamber 
fluorescence in the treated eyes (Figure 2-6). 
Fluorophotometry values for treated eyes showed statistically significant mean increased 
fluorescence in the 25-gauge treatment group as compared to the 27- and 30-gauge treatment 
groups on day 3 (P = 0.0166) and as compared to the 30-gauge treatment group on day 5 (P = 
0.0478) (Figure 2-7). When percentage increase in fluorescein concentration in the treated versus 
untreated eye is calculated no significant difference is noted between treatment groups at any 
time point (day 3 P = 0.0633 and day 5 P = 0.1919); however, when analyzed based on the 
percentage increase in the post-treatment fluorescein concentration over the baseline 
concentration a statistically significant difference remains on day 3 (P = 0.0383) with 25-gauge 
needle treated eyes having increased fluorescence as compared to 27- and 30-gauge needle 
treated eyes, but there is no significant difference on day 5 (P = 0.0978). 
There were significant differences present over time within all treatment and contralateral 
untreated eye groups (P < 0.001 by repeated measures ANOVA and Newman-Keuls posthoc; 
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Table 2-3). In the 25-gauge needle treated eyes the fluorescein concentration on day 2 was 
significantly greater than prior to aqueocentesis, day 4 and day 5. In addition, the post-
aqueocentesis and day 3 fluorescein values were greater than prior to aqueocentesis. In the 25-
gauge needle contralateral untreated eyes significantly greater fluorescence was present on days 
2 and 3 as compared to prior to and post-aqueocentesis. In the 27-gauge needle treated eyes the 
post-aqueocentesis and day 2 fluorescein values were greater than prior to aqueocentesis, day 3, 
day 4, and day 5. In addition, days 3 and 4 fluorescence was also greater than prior to 
aqueocentesis and on day 5. In the 27-gauge needle contralateral untreated eyes the fluorescein 
value on day 2 was greater than at all other time points. The day 4 fluorescein value was also 
greater than prior to aqueocentesis. In the 30-gauge needle treated eyes day 2 fluorescence was 
greater than all other time points. In the 30-gauge needle contralateral untreated eyes the 
fluorescein value on day 2 was greater than prior to aqueocentesis, post-aqueocentesis, and on 
day 5. Days 3 and 4 fluorescence were greater than prior to and post-aqueocentesis. The day 5 
fluorescein value was greater than prior to aqueocentesis. 
Though fluorescein changes were noted over time in the contralateral untreated eyes of 
all groups, no significant difference in anterior chamber fluorescence was found at any time 
point when compared to the control group (Figure 2-8). An unexpected finding was noted in the 
one control dog pulled from the study due to development of a corneal ulcer. In this dog data 
values were still collected over the 5 days and a notable rise in anterior chamber fluorescein was 
present on day 2 in the ulcerated eye, with a mild increase in fluorescence also present in the 
contralateral healthy eye (Figure 2-9).
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Table 2-3 Anterior chamber fluorescein concentrations (mean ± standard deviation in ng/ml) for treated, contralateral 
untreated, and control eyes at each study time point. 
 Pre-aqueo Post-aqueo Day 2 Day 3 Day 4 Day 5 
25-gauge treated 298.31 ± 140.94 bd 1274.96 ± 942.66*c 1953.65 ± 1360.54*a 1419.71 ± 778.85*c 800.50 ± 309.61 b 723.71 ± 278.82 b 
25-gauge contralateral 282.64 ± 116.72 b 310.53 ± 128.66 b 760.01 ± 518.49 a 631.79 ± 313.80 a 504.16 ± 250.46 509.15 ± 221.69 
27-gauge treated 355.11 ± 113.24 bd 1087.4 ± 421.49*a 1319.06 ± 348.89*a 758.02 ± 190.34*bc 662.31 ± 192.47*bc 545.18 ± 120.72 bd 
27-gauge contralateral 338.15 ± 127.35 bd 358.34 ± 111.69 b 567.73 ± 190.72 a 433.90 ± 101.22 b 459.29 ± 137.72 bc 446.44 ± 110.06 b 
30-gauge treated 290.29 ± 95.18 b 761.20 ± 418.01*b 1395.36 ± 1064.39*a 706.45 ± 338.09*b 594.96 ± 238.46 b 483.13 ± 117.62 b 
30-gauge contralateral 265.44 ± 90.74 bdf 313.71 ± 96.10 bd 651.28 ± 414.23 a 540.34 ± 243.32 c 521.43 ± 252.23 c 442.15 ± 157.54 be 
All treated eyes 314.57 ± 116.51 1041.19 ± 651.70* 1556.03 ± 1014.26* 964.40 ± 583.51* 685.93 ± 255.72* 584.00 ± 207.75 
All contralateral eyes 295.41 ± 112.22 327.53 ± 110.20 659.67 ± 389.33 535.34 ± 240.68 494.96 ± 212.00 465.91 ± 164.85 
Control eyes 286.57 ± 122.74 323.72 ± 119.42 372.83 ± 113.06 400.77 ± 125.82 349.65 ± 135.59 442.90 ± 129.31 
 
* Indicates statistically significant difference at each time point between treated and contralateral untreated eyes 
 
Statistically significant differences over time within each treated or contralateral untreated eye group: a > b, c > d, e > f
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Figure 2-4 Mean anterior chamber fluorescence (ng/ml) in 25-gauge needle treated and 
contralateral untreated eyes. 
 
* Indicates statistically significant difference at each time point between treated and contralateral 
untreated eyes 
 
Figure 2-5 Mean anterior chamber fluorescence (ng/ml) in 27-gauge needle treated and 
contralateral untreated eyes. 
 
* Indicates statistically significant difference at each time point between treated and contralateral 
untreated eyes 
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Figure 2-6 Mean anterior chamber fluorescence (ng/ml) in 30-gauge needle treated and 
contralateral untreated eyes. 
 
* Indicates statistically significant difference at each time point between treated and contralateral 
untreated eyes 
 
Figure 2-7 Mean anterior chamber fluorescence (ng/ml) in treated eyes of all groups. 
 
* Indicates statistically significant difference between the 25-gauge treatment group as compared 
to the 27-gauge and 30-gauge treatment groups on Day 3, and between the 25-gauge treatment group 
and the 30-gauge treatment group on Day 5 
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Figure 2-8 Mean anterior chamber fluorescence (ng/ml) in untreated eyes of all groups. 
 
 
Figure 2-9 Individual eyes of control dogs showing anterior chamber fluorescence.  
Note Dog 77-07 (pulled from control study) with increased fluorescence in the OS on Day 2 
following development of a corneal ulcer and also notable fluorescein increase in the 
contralateral nonulcerated OD. 
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Tonometry 
Initial tonometric readings taken on each dog were obtained both prior to and after 
application of topical anesthetic and a statistically significant difference in IOP was observed 
following topical anesthesia (no topical anesthesia, mean IOP ± s.d. = 21.20 ± 4.36 mm Hg; after 
topical anesthesia, mean IOP ± s.d. = 19.17 ± 3.60 mm Hg, P = 0.0013). This result was relevant 
for design of the study but did not have clinical significance. In order to maintain consistent and 
comparable IOP values throughout the study topical anesthesia was utilized for every tonometric 
measurement. 
When comparing the IOP between treatment groups a statistically significant difference 
was present at 20 minutes post-aqueocentesis with the 25-gauge needle treatment group 
significantly higher (32.96 ± 13.03 mm Hg) than the 27-gauge (20.15 ± 8.07 mm Hg) or 30-
gauge (19.54 ± 9.77) treatment groups (P = 0.0297) (Figure 2-10). Aside from transient ocular 
hypertension in the 25-gauge treatment group, IOP rapidly normalized in treated eyes and the 
IOP of contralateral untreated eyes showed no clinically significant changes (Figure 2-11). 
 
Figure 2-10 Mean intraocular pressure (mm Hg) of treated eyes in all groups. 
 
* Indicates statistically significant difference between the 25-gauge treatment group as compared 
to the 27-gauge and 30-gauge treatment groups 
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Figure 2-11 Mean intraocular pressure (mm Hg) of contralateral untreated eyes in all 
groups. 
 
Discussion 
Consistent with previous reports, aqueocentesis caused blood-aqueous barrier disruption 
in all treated eyes of this study. Anterior chamber fluorophotometry allowed noninvasive, 
repeated daily assessment of the breakdown and reestablishment of the blood-aqueous barrier. 
Maximal fluorescence was noted in the treated eyes of all groups on day 2 (24 hours post-
aqueocentesis), with declining values thereafter (Figure 2-7). By day 5 in all treatment groups the 
mean anterior chamber fluorescein value of the treated eyes was not significantly different than 
the contralateral untreated eyes (Table 2-3 and Figures 2-4 to 2-6). Though statistically 
significant differences were present at additional time points in some groups, values between the 
treated and contralateral untreated eyes that did not differ by more than 25% were considered 
within normal limits as has been previously reported.54 
It was of great interest to note that the contralateral untreated eyes of all groups showed 
maximal and statistically significant anterior chamber fluorescence on day 2 (Table 2-3 and 
Figure 2-8). Values declined subsequently, but no statistically significant difference was found 
between the contralateral untreated eyes and control eyes at any point in time. There are two 
possible explanations for this finding. The first supports the statistical analysis, that 
aqueocentesis treatment did not affect the contralateral eye and the value disparities over time are 
due to random variation. The second explanation is that aqueocentesis treatment did indeed 
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affect the contralateral untreated eye by causing a subtle degree of blood-aqueous barrier 
disruption as measured by fluorophotometry, but due to limited animal numbers and high 
variability (large standard deviations) a significant difference was not documented. This latter 
theory is supported by an inadvertent finding in the control dog (Dog 77-07) pulled from the 
study due to corneal ulcer development. In this dog a corneal ulcer was present in the OS on day 
2, and at that time increased anterior chamber fluorescein was measured. In addition, a mild 
spike in fluorescence was present on day 2 in the same dog’s healthy OD. These fluorescence 
changes were not noted in any other eye of the control dogs (Figure 2-9). Over days 3 through 5 
anterior chamber fluorescence in Dog 77-07 declined in both eyes as the ulcer healed. The 
increased fluorescence in the ulcerated eye of this dog is not surprising and can be attributed to 
axonal reflex causing blood-aqueous barrier breakdown.107,110 It is the increased fluorescence 
noted in this dog’s contralateral healthy eye that parallels the mean response seen in the 
contralateral eyes of treated dogs in this study. Though this finding cannot be statistically 
evaluated, it is of pertinent interest given the other study findings that suggest presence of a 
consensual ocular reaction in dog eyes. 
Consensual ocular reactions have been reported in humans and rabbits,119,145-148,174 but 
have not previously been documented in dogs. Scanning electron microscopy of rabbit eyes 
treated with paracentesis and contralateral control eyes demonstrated changes in ciliary body 
processes consistent with both a direct and consensual reaction.117 The mechanism for this 
reaction is hypothesized to be a neural reflex arc,117,147,148 but others suggest it is due to a transfer 
of prostaglandins via systemic circulation.145,146 The consensual ocular reaction is an important 
biological finding and is clinically noteworthy as it was documented immediately following and 
then up to one month following cataract surgery in humans.148 Though it is commonly 
recognized that drugs applied topically to one eye can result in effects in the opposite eye due to 
likely systemic absorption of the medication,73,129,175-178 our study is the first to suggest a 
consensual blood aqueous-barrier breakdown reaction in dogs. 
The findings in this study confirm that aqueocentesis using a 25-gauge needle caused 
greater blood-aqueous barrier breakdown than aqueocentesis with 27- or 30-gauge needles. 
Statistically significant differences were documented by anterior chamber fluorophotometry on 
days 3 and 5. Though statistically significant differences between groups were not present at the 
other time points, likely due to large standard deviations and small sample sizes, the trend of 
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increased fluorescence over time is apparent in the 25-gauge needle treatment group (Figure 2-
7). The reason for large individual variance is likely due to the uncontrolled aqueous paracentesis 
performed in this study. Though this method has been previously shown to induce large variance 
as compared to controlled, timed paracentesis,54 the former is the technique commonly employed 
during therapeutic aqueocentesis. The aim of our study was to evaluate the clinical practice of 
aqueocentesis and its effect on blood-aqueous barrier breakdown, therefore uncontrolled 
paracentesis using various needle sizes was performed.  
In this study the cause of increased blood-aqueous barrier breakdown is not clear, but 
appears to be needle size. Though the degree of ocular hypotony does affect blood-aqueous 
barrier breakdown and causes increased protein content in the reformed aqueous,121 in our study 
the average IOP immediately after aqueocentesis was not significantly different between 
treatment groups (Figure 2-10). The speed of fluid flow into the needle could also be considered 
as a cause; however, it has been shown that speed of aspiration during aqueous paracentesis had 
no effect on protein content of the reformed aqueous humor.121 Therefore, more rapid fluid 
outflow is not likely the cause of the greater blood-aqueous barrier breakdown identified in this 
study.  
Not only did 25-gauge needle aqueocentesis induce greater blood-aqueous barrier 
breakdown, but it also resulted in transient ocular hypertension 20 minutes following treatment. 
This point of elevated IOP was an unexpected finding given that in all treatment group eyes the 
IOP immediately after aqueocentesis averaged 2 mm Hg. Elevated IOP in the 25-gauge needle 
treatment group is consistent with a greater degree of blood-aqueous barrier breakdown as initial 
ocular hypertension is found in uveitis due to prostaglandin release.67,71 Paracentesis-induced 
ocular hypertension is likely due to a sudden rise in the anterior uveal blood volume with a 
subsequent increase in ultrafiltration and plasma extravasion.103,125  Paracentesis-induced blood-
aqueous barrier breakdown has been studied in dogs and results show that prostaglandins are 
indeed the most important mediators of the ocular irritative response.47 While topical 
flurbiprofen significantly reduced blood-aqueous barrier breakdown as measured by anterior 
chamber fluorophotometry,47 the inability of flurbiprofen and proparacaine to completely abolish 
the response suggests that additional non-prostaglandin, non-sensorineurally-derived mediators 
may be involved or that the rapid reduction in IOP causes physical damage to the blood-aqueous 
barrier.47,51,54  
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Though patients with glaucoma were not evaluated in the current study, the rapid 
resolution of ocular hypotony in all groups confirms the assumption that aqueocentesis alone is 
insufficient therapy for elevated IOP in dogs. This is consistent with a previous human study 
where cataract surgery patients experiencing postoperative ocular hypertension treated with 
paracentesis experienced immediate reduction in IOP followed by rebounding pressures to near 
initial values one hour after treatment.33 On the other hand, aqueous paracentesis combined with 
medical therapy provides rapid symptomatic relief of acutely elevated IOP and could be 
considered as adjunctive therapy in the management of acute elevation of IOP.31-33,45 
Data reporting and analysis of fluorophotometry studies has varied over the years with 
reports that utilize actual fluorescein concentrations, percent increase in the treated versus the 
contralateral eye, percent increase as compared to baseline, and calculation of a diffusion 
coefficient. No one method has shown to be superior. In this study actual fluorescein 
concentrations were used in an effort to avoid confounding effects by the other methods. 
Specifically, with the possibility that treatment of one eye affected anterior chamber fluorescence 
in the contralateral eye we felt it was suboptimal to use the percent increase in fluorescence in 
the treated versus contralateral eye as the means for analyzing fluorophotometry results. Laurell 
et al cautions that use of this ratio may indeed be deceptive due to a consensual reaction in the 
opposite (unoperated) eye.152 It has been reported that 5-6 hours after fluorescein injection 
aqueous humor levels fall to low or undetectable values;54 however, a trend toward increased 
anterior chamber fluorescence was noted even in control eyes over the five days of the study 
(Table 2-3 and Figure 2-9) so comparing percent increase in fluorescence to baseline may also be 
suboptimal. A diffusion coefficient for fluorescein can be calculated by fluorophotometry, 
providing a physical value for the leakage of fluorescein molecules through the blood-aqueous 
barrier. This method is reliable and reproducible as long as a strict protocol is followed, which 
involves multiple blood samples and numerous fluorophotometric measurements per eye.163 This 
method is less commonly used for investigations due to the conclusion that measurement of 
plasma fluorescence and calculation of a diffusion coefficient does not improve the clinical 
accuracy of anterior chamber fluorophotometry.156 Shah et al suggest that the concentration of 
anterior chamber fluorescence (ng/ml) is appropriate for quantification provided that patients are 
systemically well and are given the same dose of fluorescein by the same route.156 Further 
studies are warranted to determine which method of analysis is most appropriate in dogs. 
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Conclusion 
Uncontrolled aqueocentesis using 25-, 27-, and 30-gauge needles was performed in dogs 
to evaluate the degree of blood-aqueous barrier breakdown. There was no statistically significant 
difference in fluorescein concentration or IOP between 27- and 30- gauge needle treatment 
groups at any time point. Use of the 25-gauge needle resulted in a statistically significant 
increase (P < 0.05) in anterior chamber fluorescence on days 3 and 5. It also caused a statistically 
significant increase in intraocular pressure at 20 minutes post-aqueocentesis as compared to the 
27- and 30- gauge needle treatment groups. Peak anterior chamber fluorescence was documented 
in the contralateral untreated eyes of all treatment groups on day 2 suggesting a consensual 
ocular reaction in dogs; however, values were not significantly greater than control eyes. 
Substantial variability common in biological systems complicates research studies, and as in this 
investigation, high variability and large standard deviations were found to be a problem with 
statistical analysis.  
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Footnotes 
a. TonoVet®, Tiolat Ltd, Helsinki, Finland 
b. SL-14 Biomicroscope, Kowa Company, Ltd, Tokyo, Japan 
c. HEINE Omega 180® Ophthalmoscope, HEINE Optotechnik, Herrsching, Germany 
d. VetaKet®, IVX Animal Health, Inc, St. Joseph, Missouri 
e. AnaSed®, Ben Venue Laboratories, Bedford, Ohio 
f. 0.5% proparacaine hydrochloride ophthalmic solution, Akorn, Inc, Buffalo Grove, 
Illinois 
g. FM-2 Fluorotron Master, OcuMetrics, Inc, Mountain View, California 
h. AK-FLUOR®, Akorn, Inc, Buffalo Grove, Illinois 
i. WINKS 4.8 5th Ed. Statistical Analysis System, TexaSoft, Cedar Hill, TX 
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